Avastin wins FDA’s OK of new colorectal-cancer use
From MarketWatch.com - Top Stories
January 24, 2013 - 12:51pm
Drug maker Roche says the U.S. Food and Drug Administration has approved a new use of Avastin in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer.
Continue reading this article »Share This Article: